InMode to Present at Upcoming Investor Conferences

Rhea-AI Summary

InMode (INMD), a leading global provider of innovative medical technologies, has announced its participation in four major investor conferences during November and December 2024. The company will be represented at the UBS Global Healthcare Conference in California, the Jefferies London Healthcare Conference in the UK, the Canaccord Genuity MedTech Forum in New York, and the Mizuho Medical Device Summit in New York.

CFO Yair Malca and CEO Moshe Mizrahy will participate in fireside chats and one-on-one meetings. Live webcasts will be available for the UBS and Jefferies conferences, scheduled for November 12 and November 20, respectively.

News Market Reaction

+7.65%

1 alert

+7.65% News Effect

On the day this news was published, INMD gained 7.65%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

YOKNEAM, Israel, Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in November and December:

UBS Global Healthcare Conference
Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside chat moderated by Danielle Antalffy, Senior Equity Analyst, and one-on-one meetings
Location: Palos Verdes, CA
When: Tuesday, Nov. 12 at 2:00 pm PT
A live webcast of the presentation can be accessed here.

Jefferies London Healthcare Conference
Presenters: Moshe Mizrahy, Chief Executive Officer
Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings
Location: London, U.K.
When: Wednesday, Nov. 20 at 11:30 am GMT
A live webcast of the presentation can be accessed here.

Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum 
Presenters: Yair Malca, Chief Financial Officer
Format: In-person one-on-one meetings
Location: New York, NY
When: Thursday, Nov. 21

Mizuho Medical Device and Healthcare Services Summit 2024
Presenters: Yair Malca, Chief Financial Officer
Format: In-person one-on-one meetings
Location: New York, NY
When: Wednesday, Dec. 11

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-302296883.html

SOURCE InMode Ltd.

FAQ

What investor conferences will InMode (INMD) attend in November-December 2024?

InMode will attend four conferences: UBS Global Healthcare Conference (Nov 12), Jefferies London Healthcare Conference (Nov 20), Canaccord Genuity MedTech Forum (Nov 21), and Mizuho Medical Device Summit (Dec 11).

Will InMode (INMD) provide webcasts of their conference presentations?

Yes, InMode will provide live webcasts for two events: the UBS Global Healthcare Conference presentation on November 12 and the Jefferies London Healthcare Conference on November 20.

Who will represent InMode (INMD) at these investor conferences?

CFO Yair Malca will represent InMode at three conferences (UBS, Canaccord, and Mizuho), while CEO Moshe Mizrahy will present at the Jefferies London Healthcare Conference.

Where will the InMode (INMD) investor conferences take place?

The conferences will be held in Palos Verdes, CA (UBS), London, UK (Jefferies), and New York, NY (Canaccord and Mizuho).